A 28% downside call now looms over Strategy (NASDAQ: MSTR), as Monness Crespi cut its rating from ‘Neutral’ to ‘Sell’ with a price target of $65 per share.
The firm framed the downgrade as a judgment on three converging pressures: Bitcoin’s price trajectory, the company’s leverage, and the widening gap between MSTR’s market value and its underlying cryptocurrency holdings.
Monness Crespi expressed concern that the premium investors assign to Strategy’s Bitcoin-per-share growth will erode as equity dilution increasingly finances preferred stock repurchases and dividend obligations rather than BTC accumulation.
Supporting that view, regulatory filings show Strategy repurchased 2,282,510 STRC shares for $228.1 million in the week of November 9 through 15, leaving $332.2 million remaining under its preferred stock buyback program.
At that pace, the remaining repurchase capacity covers roughly 10 days of activity, underscoring how aggressively capital is being directed away from Bitcoin purchases.
The capital allocation math is striking: Strategy raised $244.7 million through common stock sales last week, channeling $206.3 million of that directly into STRC repurchases, a buyback effort nearly seven times the size of its Bitcoin acquisition that same week.
Bitcoin itself remained under pressure, slipping below $63,000 as inflation anxieties and hawkish signals from the Federal Reserve continued to weigh on digital asset markets.
Monness Crespi pointed to additional bearish indicators, noting that Bitcoin ETF outflows persist, options markets reflect elevated demand for downside protection, and prediction markets are pricing in meaningful further declines for the cryptocurrency.
MSTR shares did manage an overnight reversal into positive territory after shedding more than 6% during Wednesday’s session, though the stock remains down more than 40% so far in 2026.
Retail investors tracking the stock on Stocktwits shifted from ‘neutral’ to ‘bearish’ over a 24-hour period, with message volume classified as ‘high,’ reflecting growing unease in the retail community.
One user captured the frustration bluntly: “$MSTR Only an idiot would buy a stock that’s diluted by 2 million shares every freaking week! Should be illegal.”
The concern over dilution as a funding mechanism, rather than a growth tool, appears to be crystallizing into a broader narrative that analysts and retail traders alike are beginning to act on.